J CELL MOL MED 润色咨询

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

出版年份:2000 年文章数:5766 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2024-03-11 ms6000000921099690 来自湖北省

    偏重的研究方向:肿瘤
    经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2023-02-07 cyrain 来自山东省

    修完反回后大家awaiting EIC decision都等了大概多久呀?

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2023-10-05 ms5000002112458054 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:免疫;炎症
    经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊...

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2020-06-30 121dbfacm23暂无昵称

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。

    12

    展开12条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2023-12-29 ms8000000572778111 来自江西省

    偏重的研究方向:成骨分化
    经验分享:1205 提交 1210 under review

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2024-02-27 biocell160 来自贵州省

    24.02.20投稿,现在还是等待程序…

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2024-02-17 ms6000001781103027 来自江西省

    under review是内审还是外审?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2024-02-18 suan60 来自北京

    嘿嘿了,jcmm的car这么高也被中科院算作top了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2023-11-26 水逆退散~ 来自广西

    偏重的研究方向:肿瘤
    经验分享:Awaiting ED Assignment 11-25

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2192456, encodeId=7d2f2192456e4, content=偏重的研究方向:肿瘤<br>经验分享:请问一下系统里显示ADM:Natesan, Jayashree—— Under Review,是外审的意思吗,这个状态已经一个多月了,需要写邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848b5572951, createdName=ms6000000921099690, createdTime=Mon Mar 11 01:12:42 CST 2024, time=2024-03-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113470, encodeId=a45a21134e063, content=修完反回后大家awaiting EIC decision都等了大概多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Tue Feb 07 14:17:51 CST 2023, time=2023-02-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:一次大修一次小修,六个月接收,版面排到半年后。。。急着用,能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800491, encodeId=a9af8004911f, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:一审2个月,给了大修,4个审稿人30几条问题,要求补大量功能实验,逐一回复后补了PCR,ELISA等分子实验,一月后修回,二审一月余accept。感觉要求还是蛮高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Tue Jun 30 06:30:48 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177981, encodeId=025e21e798170, content=偏重的研究方向:成骨分化<br>经验分享:1205 提交 1210 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15e99112536, createdName=ms8000000572778111, createdTime=Fri Dec 29 12:58:14 CST 2023, time=2023-12-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2189748, encodeId=82d52189e484c, content=24.02.20投稿,现在还是等待程序…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Feb 27 21:02:48 CST 2024, time=2024-02-27, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2187883, encodeId=c4e3218e88324, content=嘿嘿了,jcmm的car这么高也被中科院算作top了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIZ7wT7fOlAz1USI4kh7pM7TEOKQcZjibKj42Hu6avoCoRy7aRZpzaCx4QAOD3WV5Xsmnv8AMmgBRA/132, createdBy=00422255419, createdName=suan60, createdTime=Sun Feb 18 08:02:52 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171068, encodeId=ba8c21e106894, content=偏重的研究方向:肿瘤<br>经验分享:Awaiting ED Assignment 11-25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散~, createdTime=Sun Nov 26 15:09:21 CST 2023, time=2023-11-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2176818, encodeId=6ab621e68187c, content=偏重的研究方向:肿瘤<br>经验分享:肿瘤生信相关文章,可以投,私我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:21:07 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省)]
    2023-12-24 投稿中 来自江苏省

    偏重的研究方向:肿瘤
    经验分享:肿瘤生信相关文章,可以投,私我

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分